Exane Derivatives’s NV5 Global NVEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$197K Sell
6,764
-496
-7% -$14.9K 0.11% 166
2022
Q1
$242K Buy
7,260
+7,244
+45,275% +$213K 0.07% 285
2021
Q4
$552 Hold
16
﹤0.01% 762
2021
Q3
$394 Sell
16
-7,932
-100% -$195K ﹤0.01% 968
2021
Q2
$190K Buy
+7,948
New +$181K 0.04% 413

Other funds holding NVEE

Exane Derivatives's NVEE Position: Q2 2022 in Review

Exane Derivatives reduced its NV5 Global (NVEE) stake by 6.8% in Q2 2022, selling an estimated $14.9K and leaving 6,764 shares worth $197K. The position accounts for 0.11% of the portfolio, ranked #166.

Exane Derivatives first reported a position in NVEE in Q2 2021 and has held it in 5 quarters since. The position peaked at $242K in Q1 2022. 205 funds tracked by Wall St. Rank hold NVEE as of Q2 2022.

  • Exane Derivatives held 6,764 shares of NV5 Global worth $197K as of Q2 2022.
  • Exane Derivatives sold 496 NV5 Global shares in Q2 2022, an estimated $14.9K.
  • NV5 Global made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #166 holding.
  • Exane Derivatives first reported a position in NV5 Global in Q2 2021 and has held it in 5 quarters since.
  • Exane Derivatives's NV5 Global position peaked at $242K in Q1 2022.
  • 205 funds tracked by Wall St. Rank held NV5 Global as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.